Tato stránka byla automaticky přeložena a přesnost překladu není zaručena. Podívejte se prosím na anglická verze pro zdrojový text.

Effect of Electroacupuncture on Bowel Function and Quality of Life in Postpartum Constipation: A Randomized Controlled Trial

1. května 2026 aktualizováno: shaimaa Mohamed hamed, MTI University
Postpartum constipation is a common condition affecting women after childbirth, leading to discomfort and reduced quality of life. Pharmacological treatments may have side effects and are sometimes avoided during breastfeeding. Electroacupuncture is a safe, non-pharmacological intervention that may improve bowel motility. However, limited evidence exists regarding its effectiveness in postpartum women, necessitating further investigation

Přehled studie

Detailní popis

to evaluate the effect of electroacupuncture on improving bowel function and reducing symptoms of postpartum constipation compared to standard care.

Study population & Sample size: (no more than 3 lines) Postpartum women aged 20-40 years diagnosed with constipation. A randomized controlled trial with two parallel groups: an electroacupuncture group and a control group receiving abdominal exercises . Participants will be randomly assigned using a simple randomization method.

Diagnosis:

Postpartum constipation diagnosed based on clinical criteria (e.g., Rome IV criteria).

Groups:

  • Group A: Electroacupuncture + abdominal exercises
  • Group B: abdominal exercises only

Inclusion Criteria:

  • Females aged 20-40 years
  • Within 6 weeks postpartum
  • Diagnosed with constipation
  • Willing to participate

Exclusion Criteria:

  • History of gastrointestinal disorders
  • Previous colorectal surgery
  • Neurological diseases affecting bowel function
  • Contraindications to acupuncture (tumor, scar or keloids & spinal instability ).

Measuring Tools:

  1. Bristol Stool Form Scale This scale will be used to assess stool consistency, which is classified into seven distinct types ranging from hard lumps to entirely liquid stool. It is considered an important indicator of intestinal transit time. The Bristol Stool Form Scale is widely validated and demonstrates high reliability and reproducibility in clinical and research settings. In this study, it will be used as a primary outcome measure to evaluate changes in bowel habits, either independently or alongside bowel movement frequency.
  2. Patient Assessment of Constipation Quality of Life (PAC-QOL) This questionnaire will be used to evaluate the impact of constipation on patients' daily life, including physical discomfort, psychosocial effects, and overall satisfaction. The PAC-QOL has excellent psychometric properties, including strong validity and reliability. In this study, it will be used as a secondary outcome measure to assess improvements in quality of life following the intervention.

    • Evaluation procedures All participants will undergo a standardized evaluation before and after the intervention period. Baseline assessment will be conducted prior to randomization to ensure comparability between groups.

At the beginning of the study, demographic and clinical data will be collected, including age, parity, mode of delivery, and time since delivery. Participants will then be evaluated for constipation severity and bowel habits.

Stool consistency will be assessed using the Bristol Stool Form Scale, where participants will classify their stool type according to the seven-point scale. In addition, participants will be instructed to record bowel movement frequency per week using a bowel diary.

Quality of life related to constipation will be evaluated using the Patient Assessment of Constipation Quality of Life (PAC-QOL) questionnaire. This tool will assess the physical, psychological, and social impact of constipation on daily living.

All outcome measures will be recorded at baseline (pre-treatment) and at the end of the treatment period (post-treatment). Participants will also be monitored throughout the study to ensure compliance and to document any adverse effects.

• Treatment procedures The electroacupuncture group will receive treatment sessions 3 times per week for 6 weeks using Quchi (LI11) and Shangjuxu (ST37) acupoints added to abdominal exercises . The control group will receive abdominal exercises only.

Typ studie

Intervenční

Zápis (Odhadovaný)

60

Fáze

  • Nelze použít

Kontakty a umístění

Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.

Studijní kontakt

Kritéria účasti

Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.

Kritéria způsobilosti

Věk způsobilý ke studiu

  • Dospělý

Přijímá zdravé dobrovolníky

Ano

Popis

Inclusion Criteria:

  • Females aged 20-40 years
  • Within 6 weeks postpartum
  • Diagnosed with constipation
  • Willing to participate

Exclusion Criteria:

  • History of gastrointestinal disorders
  • Previous colorectal surgery
  • Neurological diseases affecting bowel function
  • Contraindications to acupuncture (tumor, scar or keloids & spinal instability ).

Studijní plán

Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.

Jak je studie koncipována?

Detaily designu

  • Primární účel: Léčba
  • Přidělení: Randomizované
  • Intervenční model: Paralelní přiřazení
  • Maskování: Singl

Zbraně a zásahy

Skupina účastníků / Arm
Intervence / Léčba
Experimentální: electro acupuncture group
Participants in this group will receive electroacupuncture therapy applied to Quchi (LI11) and Shangjuxu (ST37) acupoints plus abdominal exercises Treatment will be administered [12 sessions per week] for [6 weeks], with each session lasting approximately [30 minutes]. The intervention aims to improve bowel function in postpartum constipation.

This study is expected to contribute significantly to maternal healthcare in Egypt by addressing postpartum constipation, a common yet often neglected condition affecting women after childbirth. Constipation can negatively impact quality of life, causing discomfort, pain, and psychological distress.

Electroacupuncture offers a safe, non-pharmacological, and cost-effective treatment alternative. This is particularly important for postpartum women who may avoid medications due to breastfeeding concerns or side effects.

The findings of this study may support the integration of electroacupuncture into routine postpartum care in Egypt, especially within physical therapy and rehabilitation programs. It may also help reduce dependence on laxatives and improve patient satisfaction.

Static Abdominal Contractions Lie on your back in "crook lying" (knees bent, feet flat). Gently contract all abdominal muscles (as if bracing for a light punch), hold 5-10 seconds, then release. Repeat. Keep breathing normally. This strengthens the abdominal wall to improve bowel support and tone.

Activation and exercise of the transverse abdominis muscle has been noted as important, as it brings together the bellies of the rectus abdominus muscle, improving the integrity of the linea alba and increasing fascial tension. While studied primarily for diastasis recti, these exercises engage the deep core and can support improved abdominal function overall.

Aktivní komparátor: control group
Participants in this group will perform a structured abdominal exercise program designed to improve bowel motility. Exercises will be conducted [12 sessions per week] for [6 weeks], with each session lasting approximately [20 minutes].

Static Abdominal Contractions Lie on your back in "crook lying" (knees bent, feet flat). Gently contract all abdominal muscles (as if bracing for a light punch), hold 5-10 seconds, then release. Repeat. Keep breathing normally. This strengthens the abdominal wall to improve bowel support and tone.

Activation and exercise of the transverse abdominis muscle has been noted as important, as it brings together the bellies of the rectus abdominus muscle, improving the integrity of the linea alba and increasing fascial tension. While studied primarily for diastasis recti, these exercises engage the deep core and can support improved abdominal function overall.

Co je měření studie?

Primární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Bristol Stool Form Scale
Časové okno: 6 weeks
This scale will be used to assess stool consistency, which is classified into seven distinct types ranging from hard lumps to entirely liquid stool. It is considered an important indicator of intestinal transit time. The Bristol Stool Form Scale is widely validated and demonstrates high reliability and reproducibility in clinical and research settings. In this study, it will be used as a primary outcome measure to evaluate changes in bowel habits, either independently or alongside bowel movement frequency.
6 weeks
Patient Assessment of Constipation Quality of Life (PAC-QOL)
Časové okno: 6 weeks
This questionnaire will be used to evaluate the impact of constipation on patients' daily life, including physical discomfort, psychosocial effects, and overall satisfaction. The PAC-QOL has excellent psychometric properties, including strong validity and reliability. In this study, it will be used as a secondary outcome measure to assess improvements in quality of life following the intervention.
6 weeks

Spolupracovníci a vyšetřovatelé

Zde najdete lidi a organizace zapojené do této studie.

Sponzor

Termíny studijních záznamů

Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.

Hlavní termíny studia

Začátek studia (Odhadovaný)

20. května 2026

Primární dokončení (Odhadovaný)

20. srpna 2026

Dokončení studie (Odhadovaný)

20. října 2026

Termíny zápisu do studia

První předloženo

1. května 2026

První předloženo, které splnilo kritéria kontroly kvality

1. května 2026

První zveřejněno (Aktuální)

7. května 2026

Aktualizace studijních záznamů

Poslední zveřejněná aktualizace (Aktuální)

7. května 2026

Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality

1. května 2026

Naposledy ověřeno

1. května 2026

Více informací

Termíny související s touto studií

Informace o lécích a zařízeních, studijní dokumenty

Studuje lékový produkt regulovaný americkým FDA

Ne

Studuje produkt zařízení regulovaný americkým úřadem FDA

Ne

Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .

Předplatit